Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$21.66
-2.5%
$24.53
$21.48
$53.96
$1.05B0.72496,418 shs449,057 shs
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
$45.92
+2.0%
$43.91
$37.56
$48.15
$643.38M0.7983,559 shs31,033 shs
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$161.69
-1.1%
$161.31
$136.34
$190.14
$53.35B1.431.55 million shs1.11 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
-2.48%-6.54%-16.85%-10.35%-42.05%
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
+0.37%+1.36%+2.95%+13.09%+4.40%
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
-1.08%-2.87%+1.30%+9.27%+8.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
4.3352 of 5 stars
3.12.00.03.72.04.21.3
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
4.6792 of 5 stars
3.23.02.51.93.43.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
2.25
Hold$32.3349.28% Upside
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
2.68
Moderate Buy$45.92N/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
2.40
Hold$178.5010.40% Upside

Current Analyst Ratings Breakdown

Latest AMPH, WND, IGE, GNX, and SPG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$170.00
6/17/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$159.00 ➝ $163.00
6/10/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$182.00 ➝ $169.00
5/23/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$205.00 ➝ $200.00
5/22/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$192.00 ➝ $180.00
5/13/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$168.50 ➝ $180.00
5/12/2025
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$45.00 ➝ $30.00
5/8/2025
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$40.00 ➝ $35.00
4/23/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$186.00 ➝ $159.00
(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$731.97M1.39$4.88 per share4.44$15.23 per share1.42
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
N/AN/AN/AN/AN/AN/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$5.96B8.85$11.79 per share13.71$9.84 per share16.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$159.52M$2.767.856.585.7819.38%22.20%10.40%8/6/2025 (Estimated)
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
N/AN/A16.66N/AN/AN/AN/AN/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$2.37B$6.2825.7512.559.1135.98%67.32%6.56%8/4/2025 (Estimated)

Latest AMPH, WND, IGE, GNX, and SPG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$0.71N/AN/AN/A$173.42 millionN/A
8/4/2025Q2 2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$3.04N/AN/AN/A$1.40 billionN/A
5/12/2025Q1 2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$2.91$2.95+$0.04$2.95$1.34 billion$1.47 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
N/AN/AN/AN/AN/A
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
$1.102.40%N/AN/AN/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
$8.405.20%N/A133.76%4 Years

Latest AMPH, WND, IGE, GNX, and SPG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/13/2025
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
quarterly$2.105.2%6/9/20256/9/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
0.80
2.95
2.02
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
N/AN/AN/A
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
8.29
1.45
1.45
CompanyEmployeesShares OutstandingFree FloatOptionable
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
2,02847.14 million34.18 millionOptionable
iShares North American Natural Resources ETF stock logo
IGE
iShares North American Natural Resources ETF
N/A13.65 millionN/ANot Optionable
Simon Property Group, Inc. stock logo
SPG
Simon Property Group
3,000326.42 million298.16 millionOptionable

Recent News About These Companies

SPG - Simon Property Group Inc News - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amphastar Pharmaceuticals stock logo

Amphastar Pharmaceuticals NASDAQ:AMPH

$21.66 -0.55 (-2.48%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$22.12 +0.45 (+2.10%)
As of 07/11/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

iShares North American Natural Resources ETF stock logo

iShares North American Natural Resources ETF BATS:IGE

$45.92 +0.89 (+1.97%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$45.94 +0.02 (+0.05%)
As of 07/11/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iShares North American Natural Resources ETF, formerly iShares S&P North American Natural Resources Sector Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U.S.-traded natural resource-related stocks as represented by the S&P North American Natural Resources Sector Index (the Index). The Index has been developed as an equity benchmark for the United States-traded natural resource related stocks. The Fund invests in sectors, such as oil gas & consumable fuels, energy equipment & services, metals & mining, containers & packaging, paper & forest products, construction materials and S-T Securities. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund.

Simon Property Group stock logo

Simon Property Group NYSE:SPG

$161.69 -1.76 (-1.08%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$161.35 -0.34 (-0.21%)
As of 07/11/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Simon Property Group, Inc. (NYSE:SPG) is a self-administered and self-managed real estate investment trust (REIT). Simon Property Group, L.P., or the Operating Partnership, is our majority-owned partnership subsidiary that owns all of our real estate properties and other assets. In this package, the terms Simon, we, our, or the Company refer to Simon Property Group, Inc., the Operating Partnership, and its subsidiaries. We own, develop and manage premier shopping, dining, entertainment and mixed-use destinations, which consist primarily of malls, Premium Outlets, The Mills, and International Properties. At June 30, 2024, we owned or had an interest in 230 properties comprising 183 million square feet in North America, Asia and Europe. We also owned an 84% interest in The Taubman Realty Group, or TRG, which owns 22 regional, super-regional, and outlet malls in the U.S. and Asia. Additionally, at June 30, 2024, we had a 22.4% ownership interest in Klépierre, a publicly traded, Paris-based real estate company, which owns shopping centers in 14 European countries.